Loading…

Glatiramer Acetate Modulates TNF-α and IL-10 Secretion in Microglia and Promotes Their Phagocytic Activity

Glatiramer acetate (GA) is an approved immunomodulating agent for the treatment of relapsing–remitting multiple sclerosis. Its mode of action is attributed to a T helper cell-type 1 (Th1) to Th2 cytokine shift in T cells. Th2-type GA-reactive T cells migrate into the brain and act suppressive at the...

Full description

Saved in:
Bibliographic Details
Published in:Journal of neuroimmune pharmacology 2011-09, Vol.6 (3), p.381-388
Main Authors: Pul, Refik, Moharregh-Khiabani, Darius, Škuljec, Jelena, Skripuletz, Thomas, Garde, Niklas, Voß, Elke Verena, Stangel, Martin
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c371t-6fafc4b74055ad1d5497f7e82fcd41231e79987bdc6f280437de83774bc8baea3
cites cdi_FETCH-LOGICAL-c371t-6fafc4b74055ad1d5497f7e82fcd41231e79987bdc6f280437de83774bc8baea3
container_end_page 388
container_issue 3
container_start_page 381
container_title Journal of neuroimmune pharmacology
container_volume 6
creator Pul, Refik
Moharregh-Khiabani, Darius
Škuljec, Jelena
Skripuletz, Thomas
Garde, Niklas
Voß, Elke Verena
Stangel, Martin
description Glatiramer acetate (GA) is an approved immunomodulating agent for the treatment of relapsing–remitting multiple sclerosis. Its mode of action is attributed to a T helper cell-type 1 (Th1) to Th2 cytokine shift in T cells. Th2-type GA-reactive T cells migrate into the brain and act suppressive at the sites of inflammation. However, there is increasing evidence that the effect of GA is not confined to T cells. It inhibits broadly the activation of monocytes and induces peritoneal macrophages and monocytes to differentiate into a type 2 antigen-presenting cell (APC) secreting anti-inflammatory cytokines. Thus, we examined whether GA has also direct effects on microglia cells which are involved in modifying/directing the local microenvironment in the central nervous system. Primary rat microglia were purified and cultured under standard conditions. Griess reaction was used to measure one of the stable end products of nitric oxide (NO), nitrite. Tumor necrosis factor (TNF)-alpha and interleukin-10 (IL-10) were measured in the cell culture supernatants using ELISA. Phagocytosis was quantified with a FACS-based assay. Our experiments show that GA directly modulates microglia cells. It promotes the phagocytic activity and increases the secretion of IL-10 while it decreases that of TNFα. In contrast, there was no effect on NO production. GA induces a type 2 APC differentiation of microglia suggesting a general effect on myeloid monocytic cells. Using microglia we report for the first time that GA promotes phagocytosis which could play an important role in removal of debris.
doi_str_mv 10.1007/s11481-010-9248-1
format article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_876831349</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1950797178</sourcerecordid><originalsourceid>FETCH-LOGICAL-c371t-6fafc4b74055ad1d5497f7e82fcd41231e79987bdc6f280437de83774bc8baea3</originalsourceid><addsrcrecordid>eNp1kc1O3TAQha2qVflpH6AbZKmLrkw9iXNtLxHiT7pQpNK15TiTiyGJwXYq3cfqi_SZMFyoEFJXHtnfOTOeQ8gX4PvAufyeAIQCxoEzXQnF4B3ZhqaRDDQX719qpfkW2UnphnMhBOcfyVYFXCwq2WyT25PBZh_tiJEeOMw2Iz0P3VxuMdGri2P29w-1U0fPlgw4_YkuYvZhon6i597FsBq8fQIuYxjDk-gafaSX13YV3Dp7V3yz_-3z-hP50Nsh4efnc5f8Oj66Ojxlyx8nZ4cHS-ZqCZktets70UrBm8Z20DVCy16iqnrXCahqQKm1km3nFn2luKhlh6qWUrROtRZtvUu-bXzvYrifMWUz-uRwGOyEYU5GyYWqoRa6kF_fkDdhjlMZzoBuuNQSpCoUbKjy3ZQi9uYu-tHGtQFuHoMwmyBMCcI8BmGgaPaened2xO6f4mXzBag2QCpP0wrjq9b_dX0A0dCS4w</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1950797178</pqid></control><display><type>article</type><title>Glatiramer Acetate Modulates TNF-α and IL-10 Secretion in Microglia and Promotes Their Phagocytic Activity</title><source>Springer Link</source><creator>Pul, Refik ; Moharregh-Khiabani, Darius ; Škuljec, Jelena ; Skripuletz, Thomas ; Garde, Niklas ; Voß, Elke Verena ; Stangel, Martin</creator><creatorcontrib>Pul, Refik ; Moharregh-Khiabani, Darius ; Škuljec, Jelena ; Skripuletz, Thomas ; Garde, Niklas ; Voß, Elke Verena ; Stangel, Martin</creatorcontrib><description>Glatiramer acetate (GA) is an approved immunomodulating agent for the treatment of relapsing–remitting multiple sclerosis. Its mode of action is attributed to a T helper cell-type 1 (Th1) to Th2 cytokine shift in T cells. Th2-type GA-reactive T cells migrate into the brain and act suppressive at the sites of inflammation. However, there is increasing evidence that the effect of GA is not confined to T cells. It inhibits broadly the activation of monocytes and induces peritoneal macrophages and monocytes to differentiate into a type 2 antigen-presenting cell (APC) secreting anti-inflammatory cytokines. Thus, we examined whether GA has also direct effects on microglia cells which are involved in modifying/directing the local microenvironment in the central nervous system. Primary rat microglia were purified and cultured under standard conditions. Griess reaction was used to measure one of the stable end products of nitric oxide (NO), nitrite. Tumor necrosis factor (TNF)-alpha and interleukin-10 (IL-10) were measured in the cell culture supernatants using ELISA. Phagocytosis was quantified with a FACS-based assay. Our experiments show that GA directly modulates microglia cells. It promotes the phagocytic activity and increases the secretion of IL-10 while it decreases that of TNFα. In contrast, there was no effect on NO production. GA induces a type 2 APC differentiation of microglia suggesting a general effect on myeloid monocytic cells. Using microglia we report for the first time that GA promotes phagocytosis which could play an important role in removal of debris.</description><identifier>ISSN: 1557-1890</identifier><identifier>EISSN: 1557-1904</identifier><identifier>DOI: 10.1007/s11481-010-9248-1</identifier><identifier>PMID: 21046275</identifier><language>eng</language><publisher>Boston: Springer US</publisher><subject>Animals ; Biomedical and Life Sciences ; Biomedicine ; Cell Biology ; Cell Differentiation - drug effects ; Cells, Cultured ; Enzyme-Linked Immunosorbent Assay ; Glatiramer Acetate ; Immunohistochemistry ; Immunology ; Immunosuppressive Agents - pharmacology ; Interleukin-10 - secretion ; Lymphocytes ; Microglia - drug effects ; Microglia - immunology ; Microglia - secretion ; Neurosciences ; Original Article ; Peptides - pharmacology ; Phagocytosis - drug effects ; Pharmacology/Toxicology ; Rats ; Rats, Sprague-Dawley ; T cell receptors ; Tumor Necrosis Factor-alpha - secretion ; Tumor necrosis factor-TNF ; Virology</subject><ispartof>Journal of neuroimmune pharmacology, 2011-09, Vol.6 (3), p.381-388</ispartof><rights>Springer Science+Business Media, LLC 2010</rights><rights>Journal of Neuroimmune Pharmacology is a copyright of Springer, 2011.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c371t-6fafc4b74055ad1d5497f7e82fcd41231e79987bdc6f280437de83774bc8baea3</citedby><cites>FETCH-LOGICAL-c371t-6fafc4b74055ad1d5497f7e82fcd41231e79987bdc6f280437de83774bc8baea3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27901,27902</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/21046275$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Pul, Refik</creatorcontrib><creatorcontrib>Moharregh-Khiabani, Darius</creatorcontrib><creatorcontrib>Škuljec, Jelena</creatorcontrib><creatorcontrib>Skripuletz, Thomas</creatorcontrib><creatorcontrib>Garde, Niklas</creatorcontrib><creatorcontrib>Voß, Elke Verena</creatorcontrib><creatorcontrib>Stangel, Martin</creatorcontrib><title>Glatiramer Acetate Modulates TNF-α and IL-10 Secretion in Microglia and Promotes Their Phagocytic Activity</title><title>Journal of neuroimmune pharmacology</title><addtitle>J Neuroimmune Pharmacol</addtitle><addtitle>J Neuroimmune Pharmacol</addtitle><description>Glatiramer acetate (GA) is an approved immunomodulating agent for the treatment of relapsing–remitting multiple sclerosis. Its mode of action is attributed to a T helper cell-type 1 (Th1) to Th2 cytokine shift in T cells. Th2-type GA-reactive T cells migrate into the brain and act suppressive at the sites of inflammation. However, there is increasing evidence that the effect of GA is not confined to T cells. It inhibits broadly the activation of monocytes and induces peritoneal macrophages and monocytes to differentiate into a type 2 antigen-presenting cell (APC) secreting anti-inflammatory cytokines. Thus, we examined whether GA has also direct effects on microglia cells which are involved in modifying/directing the local microenvironment in the central nervous system. Primary rat microglia were purified and cultured under standard conditions. Griess reaction was used to measure one of the stable end products of nitric oxide (NO), nitrite. Tumor necrosis factor (TNF)-alpha and interleukin-10 (IL-10) were measured in the cell culture supernatants using ELISA. Phagocytosis was quantified with a FACS-based assay. Our experiments show that GA directly modulates microglia cells. It promotes the phagocytic activity and increases the secretion of IL-10 while it decreases that of TNFα. In contrast, there was no effect on NO production. GA induces a type 2 APC differentiation of microglia suggesting a general effect on myeloid monocytic cells. Using microglia we report for the first time that GA promotes phagocytosis which could play an important role in removal of debris.</description><subject>Animals</subject><subject>Biomedical and Life Sciences</subject><subject>Biomedicine</subject><subject>Cell Biology</subject><subject>Cell Differentiation - drug effects</subject><subject>Cells, Cultured</subject><subject>Enzyme-Linked Immunosorbent Assay</subject><subject>Glatiramer Acetate</subject><subject>Immunohistochemistry</subject><subject>Immunology</subject><subject>Immunosuppressive Agents - pharmacology</subject><subject>Interleukin-10 - secretion</subject><subject>Lymphocytes</subject><subject>Microglia - drug effects</subject><subject>Microglia - immunology</subject><subject>Microglia - secretion</subject><subject>Neurosciences</subject><subject>Original Article</subject><subject>Peptides - pharmacology</subject><subject>Phagocytosis - drug effects</subject><subject>Pharmacology/Toxicology</subject><subject>Rats</subject><subject>Rats, Sprague-Dawley</subject><subject>T cell receptors</subject><subject>Tumor Necrosis Factor-alpha - secretion</subject><subject>Tumor necrosis factor-TNF</subject><subject>Virology</subject><issn>1557-1890</issn><issn>1557-1904</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><recordid>eNp1kc1O3TAQha2qVflpH6AbZKmLrkw9iXNtLxHiT7pQpNK15TiTiyGJwXYq3cfqi_SZMFyoEFJXHtnfOTOeQ8gX4PvAufyeAIQCxoEzXQnF4B3ZhqaRDDQX719qpfkW2UnphnMhBOcfyVYFXCwq2WyT25PBZh_tiJEeOMw2Iz0P3VxuMdGri2P29w-1U0fPlgw4_YkuYvZhon6i597FsBq8fQIuYxjDk-gafaSX13YV3Dp7V3yz_-3z-hP50Nsh4efnc5f8Oj66Ojxlyx8nZ4cHS-ZqCZktets70UrBm8Z20DVCy16iqnrXCahqQKm1km3nFn2luKhlh6qWUrROtRZtvUu-bXzvYrifMWUz-uRwGOyEYU5GyYWqoRa6kF_fkDdhjlMZzoBuuNQSpCoUbKjy3ZQi9uYu-tHGtQFuHoMwmyBMCcI8BmGgaPaened2xO6f4mXzBag2QCpP0wrjq9b_dX0A0dCS4w</recordid><startdate>20110901</startdate><enddate>20110901</enddate><creator>Pul, Refik</creator><creator>Moharregh-Khiabani, Darius</creator><creator>Škuljec, Jelena</creator><creator>Skripuletz, Thomas</creator><creator>Garde, Niklas</creator><creator>Voß, Elke Verena</creator><creator>Stangel, Martin</creator><general>Springer US</general><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope></search><sort><creationdate>20110901</creationdate><title>Glatiramer Acetate Modulates TNF-α and IL-10 Secretion in Microglia and Promotes Their Phagocytic Activity</title><author>Pul, Refik ; Moharregh-Khiabani, Darius ; Škuljec, Jelena ; Skripuletz, Thomas ; Garde, Niklas ; Voß, Elke Verena ; Stangel, Martin</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c371t-6fafc4b74055ad1d5497f7e82fcd41231e79987bdc6f280437de83774bc8baea3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>Animals</topic><topic>Biomedical and Life Sciences</topic><topic>Biomedicine</topic><topic>Cell Biology</topic><topic>Cell Differentiation - drug effects</topic><topic>Cells, Cultured</topic><topic>Enzyme-Linked Immunosorbent Assay</topic><topic>Glatiramer Acetate</topic><topic>Immunohistochemistry</topic><topic>Immunology</topic><topic>Immunosuppressive Agents - pharmacology</topic><topic>Interleukin-10 - secretion</topic><topic>Lymphocytes</topic><topic>Microglia - drug effects</topic><topic>Microglia - immunology</topic><topic>Microglia - secretion</topic><topic>Neurosciences</topic><topic>Original Article</topic><topic>Peptides - pharmacology</topic><topic>Phagocytosis - drug effects</topic><topic>Pharmacology/Toxicology</topic><topic>Rats</topic><topic>Rats, Sprague-Dawley</topic><topic>T cell receptors</topic><topic>Tumor Necrosis Factor-alpha - secretion</topic><topic>Tumor necrosis factor-TNF</topic><topic>Virology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Pul, Refik</creatorcontrib><creatorcontrib>Moharregh-Khiabani, Darius</creatorcontrib><creatorcontrib>Škuljec, Jelena</creatorcontrib><creatorcontrib>Skripuletz, Thomas</creatorcontrib><creatorcontrib>Garde, Niklas</creatorcontrib><creatorcontrib>Voß, Elke Verena</creatorcontrib><creatorcontrib>Stangel, Martin</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest - Health &amp; Medical Complete保健、医学与药学数据库</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of neuroimmune pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Pul, Refik</au><au>Moharregh-Khiabani, Darius</au><au>Škuljec, Jelena</au><au>Skripuletz, Thomas</au><au>Garde, Niklas</au><au>Voß, Elke Verena</au><au>Stangel, Martin</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Glatiramer Acetate Modulates TNF-α and IL-10 Secretion in Microglia and Promotes Their Phagocytic Activity</atitle><jtitle>Journal of neuroimmune pharmacology</jtitle><stitle>J Neuroimmune Pharmacol</stitle><addtitle>J Neuroimmune Pharmacol</addtitle><date>2011-09-01</date><risdate>2011</risdate><volume>6</volume><issue>3</issue><spage>381</spage><epage>388</epage><pages>381-388</pages><issn>1557-1890</issn><eissn>1557-1904</eissn><abstract>Glatiramer acetate (GA) is an approved immunomodulating agent for the treatment of relapsing–remitting multiple sclerosis. Its mode of action is attributed to a T helper cell-type 1 (Th1) to Th2 cytokine shift in T cells. Th2-type GA-reactive T cells migrate into the brain and act suppressive at the sites of inflammation. However, there is increasing evidence that the effect of GA is not confined to T cells. It inhibits broadly the activation of monocytes and induces peritoneal macrophages and monocytes to differentiate into a type 2 antigen-presenting cell (APC) secreting anti-inflammatory cytokines. Thus, we examined whether GA has also direct effects on microglia cells which are involved in modifying/directing the local microenvironment in the central nervous system. Primary rat microglia were purified and cultured under standard conditions. Griess reaction was used to measure one of the stable end products of nitric oxide (NO), nitrite. Tumor necrosis factor (TNF)-alpha and interleukin-10 (IL-10) were measured in the cell culture supernatants using ELISA. Phagocytosis was quantified with a FACS-based assay. Our experiments show that GA directly modulates microglia cells. It promotes the phagocytic activity and increases the secretion of IL-10 while it decreases that of TNFα. In contrast, there was no effect on NO production. GA induces a type 2 APC differentiation of microglia suggesting a general effect on myeloid monocytic cells. Using microglia we report for the first time that GA promotes phagocytosis which could play an important role in removal of debris.</abstract><cop>Boston</cop><pub>Springer US</pub><pmid>21046275</pmid><doi>10.1007/s11481-010-9248-1</doi><tpages>8</tpages></addata></record>
fulltext fulltext
identifier ISSN: 1557-1890
ispartof Journal of neuroimmune pharmacology, 2011-09, Vol.6 (3), p.381-388
issn 1557-1890
1557-1904
language eng
recordid cdi_proquest_miscellaneous_876831349
source Springer Link
subjects Animals
Biomedical and Life Sciences
Biomedicine
Cell Biology
Cell Differentiation - drug effects
Cells, Cultured
Enzyme-Linked Immunosorbent Assay
Glatiramer Acetate
Immunohistochemistry
Immunology
Immunosuppressive Agents - pharmacology
Interleukin-10 - secretion
Lymphocytes
Microglia - drug effects
Microglia - immunology
Microglia - secretion
Neurosciences
Original Article
Peptides - pharmacology
Phagocytosis - drug effects
Pharmacology/Toxicology
Rats
Rats, Sprague-Dawley
T cell receptors
Tumor Necrosis Factor-alpha - secretion
Tumor necrosis factor-TNF
Virology
title Glatiramer Acetate Modulates TNF-α and IL-10 Secretion in Microglia and Promotes Their Phagocytic Activity
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-30T07%3A18%3A12IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Glatiramer%20Acetate%20Modulates%20TNF-%CE%B1%20and%20IL-10%20Secretion%20in%20Microglia%20and%20Promotes%20Their%20Phagocytic%20Activity&rft.jtitle=Journal%20of%20neuroimmune%20pharmacology&rft.au=Pul,%20Refik&rft.date=2011-09-01&rft.volume=6&rft.issue=3&rft.spage=381&rft.epage=388&rft.pages=381-388&rft.issn=1557-1890&rft.eissn=1557-1904&rft_id=info:doi/10.1007/s11481-010-9248-1&rft_dat=%3Cproquest_cross%3E1950797178%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c371t-6fafc4b74055ad1d5497f7e82fcd41231e79987bdc6f280437de83774bc8baea3%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1950797178&rft_id=info:pmid/21046275&rfr_iscdi=true